Status:
COMPLETED
Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Bone and Joint Infection
Osteomyelitis
Eligibility:
All Genders
18-90 years
Brief Summary
The aim of this study is to adescription of mandibular osteomylitis in patients having had a treatment by DENOSUMAB. Indeed, one of the adverse effect ot this molecule is to induce mandibular infectio...
Eligibility Criteria
Inclusion
- patients having a mandibular osteomylelitis due to DENOSUMAB
Exclusion
- none
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT03808285
Start Date
January 1 2013
End Date
December 31 2018
Last Update
February 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France, 69004